ClinicalTrials.gov record
Terminated Phase 2 Interventional

BHV-7000 Open-Label Extension Bipolar Mania Study

ClinicalTrials.gov ID: NCT06423794

Public ClinicalTrials.gov record NCT06423794. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 8:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of BHV-7000 in Treatment of Bipolar I Disorder

Study identification

NCT ID
NCT06423794
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biohaven Therapeutics Ltd.
Industry
Enrollment
94 participants

Conditions and interventions

Interventions

  • BHV-7000 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 23, 2024
Primary completion
Apr 24, 2025
Completion
Apr 24, 2025
Last update posted
Dec 15, 2025

2024 – 2025

United States locations

U.S. sites
32
U.S. states
12
U.S. cities
29
Facility City State ZIP Site status
Pillar Clinical Research, LLC Bentonville Arkansas 72712
WIRG Little Rock Arkansas 72211
WRN Rogers Arkansas 72758
Advanced Research Center, Inc. Anaheim California 92805
CIT LA Bellflower California 90706
ProScience Research Group Culver City California 90230
Cenexel CNS Garden Grove California 92845
Synergy San Diego Lemon Grove California 91945
NRC Research Institute Orange California 92868
CIT IE Riverside California 92506
Cenexel CNS Torrance California 90504
Segal Trials - Larkin Behavioral Health Services-Inpatient & Early Phase Site Hollywood Florida 33021
Cenexel - RCA Hollywood Florida 33024
LCC Medical Research Inst Miami Florida 33126
Floridian Neuroscience Institute Miami Lakes Florida 33016
Segal Trials - Miami Lakes Medical Research-Inpatient & Early Phase Site Miami Lakes Florida 33016
Neuroscience Research Institute West Palm Beach Florida 33407
Atlanta Center for Medical Research Atlanta Georgia 30331
CenExel iResearch, LLC Decatur Georgia 30030
CenExel iResearch, LLC Savannah Georgia 31405
Uptown Research Institute Chicago Illinois 60640
Pillar Clinical Research Chicago Illinois 60641
CBH Health Gaithersburg Maryland 20877
Precise Clinical Research Flowood Mississippi 39232
Arch Clinical Trials St Louis Missouri 63141
Hassman Research Institute Marlton New Jersey 08053
RBA Staten Island New York 10329
Midwest Clinical Research Center Dayton Ohio 45417
NBCR North Canton Ohio 44720
Community Clinical Research, Inc. Austin Texas 78754
InSite Clinical Research, LLC DeSoto Texas 75115
Pillar Clinical Research, LLC Richardson Texas 75080

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06423794, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06423794 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →